2A2X | Hydrolase Hydrolase Inhibitor | date | Jun 23, 2005 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Orally Active Thrombin Inhibitors In Complex With Thrombin I | ||||||||||||||
authors | U.E.W.Lange, D.Baucke, W.Hornberger, H.Mack, W.Seitz, H.W.Hoeffke | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Thrombin Light Chain Chain: L |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 | ||||||||||||||
Molecule: Thrombin Heavy Chain Chain: H Synonym: Coagulation Factor II Ec: 3.4.21.5 |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 | ||||||||||||||
Molecule: Synthetic Peptide Chain: P Engineered: Yes |
Synthetic: Yes Organism_scientific: Synthetic Other_details: Synthetic Peptide | ||||||||||||||
symmetry | Space Group: C 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.44 Å | ||||||||||||
ligand | ALC, HYP, NA9, SIN, SMF BindingDB | enzyme | Hydrolase E.C.3.4.21.5 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Orally active thrombin inhibitors. Part 2: optimization of the P2-moiety., Lange UE, Baucke D, Hornberger W, Mack H, Seitz W, Hoffken HW, Bioorg Med Chem Lett. 2006 May 15;16(10):2648-53. Epub 2006 Feb 3. PMID:16460939 |
Data retrieval |
View 2A2X in 3D |
Visual 3D analysis of 2A2X |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2A2X |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |